Clinical Trials Browser

peginterferon alfa-2b × Endocrine × Clear all

NCT00055809 2013-01-23

Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors

Phase 2 Completed

EndocrineGastrointestinal

Metastatic Gastrointestinal Carcinoid Tumor